Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

por Storebjerg, Tine Maj, Strand, Siri H., Høyer, Søren, Lynnerup, Anne-Sofie, Borre, Michael, Ørntoft, Torben F., Sørensen, Karina D.
Publicado 2018

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer

por Strand, Siri H., Hoyer, Soren, Lynnerup, Anne-Sofie, Haldrup, Christa, Storebjerg, Tine Maj, Borre, Michael, Orntoft, Torben F., Sorensen, Karina D.
Publicado 2015

Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis

por Nørgaard, Maibritt, Haldrup, Christa, Storebjerg, Tine Maj, Vestergaard, Else Marie, Wild, Peter J., Høyer, Søren, Borre, Michael, Ørntoft, Torben Falck, Sørensen, Karina Dalsgaard
Publicado 2017